ArticlePPAR research2015

PPAR-α Agonist Fenofibrate Decreased Serum Irisin Levels in Type 2 Diabetes Patients with Hypertriglyceridemia.

Xiaomeng Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.